Track Categories

The track category is the heading under which your abstract will be reviewed and later published in the conference printed matters if accepted. During the submission process, you will be asked to select one track category for your abstract.

  • Track 1-1Pathological fractures
  • Track 1-2Injuries to jonts
  • Track 1-3Injuries to ligaments
  • Track 1-4Injuries to muscles and tendons
  • Track 1-5Knee arthoplasty
  • Track 1-6Classification of fractures
  • Track 2-1Types of bone marrow
  • Track 2-2Stroma
  • Track 2-3Cellular components
  • Track 2-4Mesenchymal stem cells
  • Track 2-5Lymphocytes
  • Track 2-6Inflamatory bowel disease
  • Track 2-7Bone marrow transplants
  • Track 3-1Advantages
  • Track 3-2Procedure
  • Track 3-3Indications
  • Track 3-4Limitations
  • Track 3-5Advantages
  • Track 4-1Tuberculosis of the spine
  • Track 4-2Tuberculosis of the hipe
  • Track 4-3Tuberculosis of knee
  • Track 4-4Tuberculosis of osteomyelitis
  • Track 5-1Future perspectives
  • Track 5-2Effective management of pain management
  • Track 5-3Pharmacological treatment
  • Track 5-4Non pharmacological therapies
  • Track 6-1Rheumatic fever
  • Track 6-2Pediatric Rheumatology
  • Track 6-3Carpel tunnel syndrome
  • Track 6-4Systemic conditions and connective tissue diseases
  • Track 6-5Degenerative arthropathies
  • Track 6-6Inflammatory Rheumatism
  • Track 7-1Novel Metal Suppression Techniques
  • Track 7-2MR Arthrography
  • Track 7-3Tomosynthesis
  • Track 7-4Bone Mineral Density Measurements Using DXA
  • Track 7-53D Ultrasound imaging for musculoskeletal tissues
  • Track 7-6Ultrasound elastography
  • Track 7-7Ultrasonography
  • Track 7-8Musculoskeletal imaging in rheumatology
  • Track 8-1Sarcoidosis
  • Track 8-2Inflammatory Myositis
  • Track 8-3Polymyalgia Rheumatica
  • Track 8-4Tendinitis and Bursitis
  • Track 8-5Lyme disease
  • Track 8-6Ankylosing spondylitis
  • Track 8-7Gout and Pseudo Gout
  • Track 8-8Sjogren Syndrome
  • Track 8-9Scleroderma and Vasculitis
  • Track 8-10Rheumatic fever
  • Track 9-1Systemic lupus erythematosus (SLE)
  • Track 9-2Discoid lupus erythematosus
  • Track 9-3drug-induced lupus erythematosus
  • Track 9-4neonatal lupus erythematosus
  • Track 9-5Pathophysiology Diagnosis
  • Track 9-6Treatment Hope for the Future
  • Track 10-1Treatment of Ankylosing Spondylitis
  • Track 10-2Ankylosing spondylitis (AS) and cardiovascular disease
  • Track 10-3Diagnosis of Ankylosing spondylitis Treatment of AS
  • Track 10-4Treatment of AS
  • Track 10-5Pharmacological Treatment of AS
  • Track 10-6Clinical trials on AS
  • Track 10-7Non pharmacological therapies for AS Clinical trials on AS
  • Track 11-1Sign and symptoms of Rheumatic Arthritis
  • Track 11-2Risk factor of Rheumatic Arthritis
  • Track 11-3Juvenile Rheumatoid Arthritis
  • Track 11-4Application of TNF α and IL-1 drugs in Rheumatic Arthritis
  • Track 11-5Treatments of Rheumatic Arthritis
  • Track 11-6Pharmacological Treatment of RA
  • Track 11-7Non-pharmacological treatment of RA
  • Track 11-8Emerging therapies
  • Track 11-9Gene array analysis in Rheumatic Arthritis
  • Track 12-1Primary hyperuricaemia
  • Track 12-2Secondary hyperuricaemia
  • Track 12-3Pthophysiology
  • Track 12-4Diagnosis of Gout Prevention
  • Track 12-5Pharmacological treatment of gout
  • Track 13-1Tennis Elbow
  • Track 13-2Scurvy
  • Track 13-3Golfers Elbow
  • Track 13-4Myofascial Pain
  • Track 13-5Myositis
  • Track 13-6Mixed Connective Tissue Disease
  • Track 13-7Serum Sickness
  • Track 13-8Beurger Disease
  • Track 14-1Knee Injuries and Osteoarthritis
  • Track 14-2Advanced treatment for Osteoarthritis
  • Track 14-3Osteoarthritis affecting Cartilage
  • Track 14-4Natural remedies for Osteoarthritis
  • Track 14-5Tennis Elbow
  • Track 15-1Sings and sympoms
  • Track 15-2Fatigue
  • Track 15-3Anemia
  • Track 15-4Causes of PMR
  • Track 15-5Treatment of polymylgia rheumatica
  • Track 16-1Types of psoriatic arthritis
  • Track 16-2Causes of Psoriatic Arthritis
  • Track 16-3Disease modifying antirheumatic drugs
  • Track 16-4Spondylitis
  • Track 17-1Sings and sympoms
  • Track 17-2Dermatomyositis
  • Track 17-3Causes
  • Track 17-4Diagnosis
  • Track 17-5Corticosteroids
  • Track 18-1Gene array analysis in Rheumatic Arthritis
  • Track 18-2Causes and risk factors
  • Track 18-3Pharmacological treatment of RA
  • Track 19-1Arthroplasty and total joint reconstruction
  • Track 19-2Joint and knee replacement treatment
  • Track 19-3Biologic agents and therapies for Rheumatoid Arthritis
  • Track 19-4Disease-modifying anti Rheumatic drugs
  • Track 19-5Immunological treatment of Rheumatic Disorders
  • Track 19-6Physiotherapeutic treatments and advances
  • Track 19-7Physiotherapy Instruments
  • Track 20-1Knee arthroplasty
  • Track 20-2Hip Arthoplasty
  • Track 20-3 Ligament reconstruction
  • Track 20-4Interpositional reconstruction
  • Track 20-5 Resurfacing arthroplasty
  • Track 21-1Ankylosing spondylitis
  • Track 21-2Juvenile idiopathic arthritis
  • Track 21-3Septic arthritis
  • Track 21-4Gout and pseudo-gout
  • Track 21-5Physical and occupational therapy
  • Track 21-6Rheumatoid arthritis
  • Track 21-7Arthroscopic surgery
  • Track 22-1Fibromyalgia prevalence
  • Track 22-2Causes and risk factors
  • Track 22-3Symptoms of Fibromyalgia
  • Track 22-4Diagnosis and treatment
  • Track 22-5Fibromyalgia complications